314 related articles for article (PubMed ID: 8937710)
21. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
Ohmura T; Oshita M; Kigoshi S; Muramatsu I
Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
[TBL] [Abstract][Full Text] [Related]
22. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta.
Lima V; Mueller A; Kamikihara SY; Raymundi V; Alewood D; Lewis RJ; Chen Z; Minneman KP; Pupo AS
Eur J Pharmacol; 2005 Jan; 508(1-3):183-92. PubMed ID: 15680270
[TBL] [Abstract][Full Text] [Related]
23. Sympathetic neurotransmission in the rat testicular capsule: functional characterization and identification of mRNA encoding alpha1-adrenoceptor subtypes.
Jurkiewicz NH; Caricati-Neto A; Verde LF; Avellar MC; Reuter HR; Jurkiewicz A
Eur J Pharmacol; 2006 Aug; 543(1-3):141-50. PubMed ID: 16822496
[TBL] [Abstract][Full Text] [Related]
24. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
Hussain MB; Marshall I
Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the alpha 1-adrenoceptor subtype mediating contraction of guinea-pig spleen.
Eltze M
Eur J Pharmacol; 1994 Aug; 260(2-3):211-20. PubMed ID: 7988645
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological evaluation of N-methyl-actinodaphnine, a new vascular alpha-adrenoceptor antagonist, isolated from Illigera luzonensis.
Guh JH; Ko FN; Yu SM; Wu YC; Teng CM
Eur J Pharmacol; 1995 Jun; 279(1):33-41. PubMed ID: 7556380
[TBL] [Abstract][Full Text] [Related]
27. Sympathectomy reveals alpha 1A- and alpha 1D-adrenoceptor components to contractions to noradrenaline in rat vas deferens.
Cleary L; Slattery J; Bexis S; Docherty JR
Br J Pharmacol; 2004 Nov; 143(6):745-52. PubMed ID: 15451776
[TBL] [Abstract][Full Text] [Related]
28. Buspirone functionally discriminates tissues endowed with alpha1-adrenoceptor subtypes A, B, D and L.
Eltze M; König H; Ullrich B; Grebe T
Eur J Pharmacol; 1999 Jul; 378(1):69-83. PubMed ID: 10478567
[TBL] [Abstract][Full Text] [Related]
29. KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.
Shibata K; Foglar R; Horie K; Obika K; Sakamoto A; Ogawa S; Tsujimoto G
Mol Pharmacol; 1995 Aug; 48(2):250-8. PubMed ID: 7651358
[TBL] [Abstract][Full Text] [Related]
30. The effects of tamsulosin, a high affinity antagonist at functional alpha 1A- and alpha 1D-adrenoceptor subtypes.
Noble AJ; Chess-Williams R; Couldwell C; Furukawa K; Uchyiuma T; Korstanje C; Chapple CR
Br J Pharmacol; 1997 Jan; 120(2):231-8. PubMed ID: 9117115
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part I.
Leonardi A; Hieble JP; Guarneri L; Naselsky DP; Poggesi E; Sironi G; Sulpizio AC; Testa R
J Pharmacol Exp Ther; 1997 Jun; 281(3):1272-83. PubMed ID: 9190863
[TBL] [Abstract][Full Text] [Related]
32. Identification of alpha 1-adrenoceptor subtypes in the human prostatic urethra.
Taniguchi N; Ukai Y; Tanaka T; Yano J; Kimura K; Moriyama N; Kawabe K
Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):412-6. PubMed ID: 9089674
[TBL] [Abstract][Full Text] [Related]
33. Effects of tamsulosin metabolites at alpha-1 adrenoceptor subtypes.
Taguchi K; Saitoh M; Sato S; Asano M; Michel MC
J Pharmacol Exp Ther; 1997 Jan; 280(1):1-5. PubMed ID: 8996174
[TBL] [Abstract][Full Text] [Related]
34. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.
Aboud R; Shafii M; Docherty JR
Br J Pharmacol; 1993 May; 109(1):80-7. PubMed ID: 8098642
[TBL] [Abstract][Full Text] [Related]
35. Functional evidence for an alpha 1B-adrenoceptor mediating contraction of the mouse spleen.
Eltze M
Eur J Pharmacol; 1996 Sep; 311(2-3):187-98. PubMed ID: 8891599
[TBL] [Abstract][Full Text] [Related]
36. A-315456: a selective alpha(1D)-adrenoceptor antagonist with minimal dopamine D(2) and 5-HT(1A) receptor affinity.
Buckner SA; Milicic I; Daza A; Lynch JJ; Kolasa T; Nakane M; Sullivan JP; Brioni JD
Eur J Pharmacol; 2001 Dec; 433(1):123-7. PubMed ID: 11755142
[TBL] [Abstract][Full Text] [Related]
37. In vivo demonstration of alpha(1A)-adrenoceptor subtype selectivity of KMD-3213 in rat tissues.
Yamada S; Okura T; Kimura R
J Pharmacol Exp Ther; 2001 Jan; 296(1):160-7. PubMed ID: 11123376
[TBL] [Abstract][Full Text] [Related]
38. Discrimination of alpha1-adrenoceptor subtypes in rat aorta and prostate.
Maruyama K; Suzuki M; Tsuchiya M; Makara Y; Hattori K; Ohnuki T; Watanabe K; Nagatomo T
Pharmacology; 1998 Aug; 57(2):88-95. PubMed ID: 9691228
[TBL] [Abstract][Full Text] [Related]
39. The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist.
Brown CM; MacKinnon AC; Redfern WS; Hicks PE; Kilpatrick AT; Small C; Ramcharan M; Clague RU; Clark RD; MacFarlane CB
Br J Pharmacol; 1993 Feb; 108(2):516-25. PubMed ID: 8095420
[TBL] [Abstract][Full Text] [Related]
40. Functional studies on alpha 1-adrenoceptor subtypes mediating inotropic effects in rat right ventricle.
Michel MC; Hanft G; Gross G
Br J Pharmacol; 1994 Feb; 111(2):539-46. PubMed ID: 7911719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
